Bronchiectasis with (acute) exacerbation
ICD-10 J47.1 is a billable code used to indicate a diagnosis of bronchiectasis with (acute) exacerbation.
Bronchiectasis with (acute) exacerbation is characterized by the abnormal and permanent dilation of the bronchi, leading to chronic respiratory symptoms and recurrent infections. Clinically, patients may present with a chronic productive cough, purulent sputum, hemoptysis, and dyspnea. The anatomy involved includes the bronchi and bronchioles, which become inflamed and damaged due to repeated infections or obstruction. Disease progression can lead to significant lung damage, respiratory failure, and complications such as pneumonia. Diagnostic considerations include a thorough patient history, physical examination, imaging studies like high-resolution CT scans, and pulmonary function tests to assess lung capacity and airflow obstruction. Laboratory tests may also be performed to identify underlying causes, such as cystic fibrosis or immunodeficiency disorders. The exacerbation phase is marked by a sudden worsening of symptoms, often requiring increased medical intervention, including antibiotics and possibly hospitalization.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J47.1 covers bronchiectasis that is currently experiencing an acute exacerbation, which may be triggered by infections, allergens, or environmental factors. It is essential to document the acute nature of the exacerbation to support this code.
J47.1 should be used when a patient with bronchiectasis presents with an acute worsening of symptoms, requiring additional treatment or hospitalization. If the patient is stable or has chronic bronchiectasis without exacerbation, J47.0 should be used instead.
Documentation should include the patient's history of bronchiectasis, details of the acute exacerbation (e.g., increased sputum production, fever), results from imaging studies, and treatment plans. Clear notes on the patient's response to treatment are also critical.
